Oncology Pharma - ONPH Short Interest Ratio & Short Volume

Short interest is the volume of Oncology Pharma shares that have been sold short but have not yet been closed out or covered. As of January 15th, investors have sold 23,600 shares of ONPH short. Learn More on Oncology Pharma's current short interest.

Oncology Pharma saw a drop in short interest during the month of January. As of January 15th, there was short interest totaling 23,600 shares, a drop of 32.2% from the previous total of 34,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to Oncology Pharma: Leafly Holdings, Inc. (2.52%), Alterity Therapeutics Limited (0.34%), Check-Cap Ltd. (0.43%), PURE Bioscience, Inc. (0.00%), Heart Test Laboratories, Inc. (0.39%), Graybug Vision, Inc. (0.36%), Galmed Pharmaceuticals Ltd. (0.66%), PolyPid Ltd. (3.61%), Lucira Health, Inc. (4.04%), and Sharps Technology, Inc. (2.44%).

As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($3.43 billion), T. Rowe Price Group, Inc. ($2.26 billion), Coinbase Global, Inc. ($2.19 billion), Etsy, Inc. ($1.78 billion), Paramount Global ($1.77 billion), Old Dominion Freight Line, Inc. ($1.69 billion), United Rentals, Inc. ($1.53 billion), American Airlines Group Inc. ($1.52 billion), PG&E Co. ($1.48 billion), and Voya Financial, Inc. ($1.47 billion). View all of the most shorted stocks.

Short selling ONPH is an investing strategy that aims to generate trading profit from Oncology Pharma as its price is falling. ONPH shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Oncology Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ONPH, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ONPH, twice per month. The most recent reporting period available is January, 15 2023.